Barbiturates for acute neurological and neurosurgical emergencies - Do they still have a role?

Journal of Clinical Neuroscience

Volumn 10, Issue 3, 2003, Pages 283-288

  Cordato, Dennis J ^a   Herkes, Geoffrey K ^a   Mather, Laurence E ^b   Morgan, Michael K ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BARBITURIC ACID DERIVATIVE; HEXOBARBITAL; METHOHEXITAL; METHYLPHENOBARBITAL; PENTOBARBITAL; PHENOBARBITAL; SECOBARBITAL; THIOPENTAL;

BRAIN INJURY; BRAIN VASOSPASM; CARDIOPULMONARY INSUFFICIENCY; CEREBROVASCULAR ACCIDENT; DRUG EFFICACY; EPILEPSY; HUMAN; HYPOKALEMIA; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; STEREOISOMERISM; SUBARACHNOID HEMORRHAGE;

EID: 0037833481     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(03)00034-1     Document Type: Review

References (97)

1. Dundee JW, McIlroy PDA. The history of the barbiturates. Anaesthesia 1982; 37: 726-734.
2. Harvey SC. Hypnotics and sedatives. The barbiturates. In: Goodman LS, Gilman A (eds) The Pharmacological Basis of Therapeutics. fifth ed. Macmillan, New York 1975; 102-123.
3. Willow M, Johnston GAR. Pharmacology of barbiturates: electrophysiological and neurochemical studies. Int Rev Neurobiol 1983; 24: 15-49.
4. Brodie MJ, Dichter MA. Established antiepileptic drugs. Seizure 1997; 6: 159-174.
5. Dundee JW. Barbiturates. In: Dundee JW. Clarke RSJ, McCaughey W (eds) Clinical Anaesthetic Pharmacology. Churchill Livingstone, New York 1991; 137-154.
6. Dundee JW. Fifty years of thiopentone. Br J Anaesth 1984; 56: 211-213.
7. Chan HNJ, Morgan DJ, Crankshaw DP, Boyd MD. Pentobarbitone formation during thiopentone infusion. Anaesthesia 1985; 40: 1155-1159.
8. Cordato DJ, Gross AS, Herkes GK, Mather LE. Pharmacokinetics of thiopentone enantiomers following intravenous injection or prolonged infusion of rac-thiopentone. Br J Clin Pharmacol 1997; 43: 355-362.
9. Cordato, DJ, Mather LE, Gross AS, Herkes GK. Pharmacokinetics of thiopental enantiomers during and following prolonged high-dose therapy. Anesthesiology 1999; 91: 1693-1702.
10. Akaike N, Hattori K, Inomata N, Oomura Y. γ-Aminobutyric acid and pentobarbitone-gated chloride currents in internally perfused frog sensory neurons. J Physiol 1985; 360: 367-386.
11. Akaike N, Maruyama T, Tokutomi N. Kinetic properties of the pentobarbitone-gated chloride current in frog sensory neurons. J Physiol 1987; 394: 85-98.
12. French-Mullen JMH, Barker JL, Rogawski MA. Calcium current block by (-)-pentobarbital, phenobarbital and CHEB but not (+)-pentobarbital in acutely isolated hippocampal CA1 neurons: comparison with effects on GABA-activated Cl-current. J Neurosci 1993; 13: 3211-3221.
13. Huang L-YM, Barker JL. Pentobarbital: stereospecific actions of (+) and (-) isomers revealed on cultured mammalian neurons. Science 1980; 207: 195-197.
14. Leeb-Lundberg F, Olsen RW. Interactions of barbiturates of various pharmacological categories with benzodiazepine receptors. Mol Pharmacol 1982; 21: 320-328.
15. A receptor by depressant barbiturates and pregnane steroids. Br J Pharmacol 1988; 94: 1257-1269.
16. A receptor: dependence on receptor subunit combination. Br J Pharmacol 1996; 117: 521-527.
17. Macdonald RL, McLean MJ. Cellular bases of barbiturate and phenytoin anticonvulsant drug action. Epilepsia 1982; 23(Suppl. 1): S7-S18.
18. 2+ on the resting and K-stimulated release of endogenous neurotransmitters from rat midbrain slices. Biochem Pharmacol 1980; 29: 2189-2198.
19. Zhu H, Cottrell JE, Kass IS. The effect of thiopental and propofol on NMDA- and AMPA-mediated glutamate excitotoxicity. Anesthesiology 1997; 87: 944-951.
20. Blaustein MP, Ector AC. Barbiturate inhibition of calcium uptake by nerve terminals in vitro. Mol Pharmacol 1975; 11: 369-378.
21. Shibuta S, Kosaka J, Mashimo T, Fukuda Y, Yoshiya I. Nitric oxide-induced cytotoxicity attenuation by thiopentone sodium but not pentobarbitone sodium in primary brain cultures. Br J Pharmacol 1998; 124: 804-810.
22. Björkman S, Nilsson F, Akeson J, Messeter K, Rosen I. The effect of thiopental on cerebral blood flow, and its relation to plasma concentration, during simulated induction of anaesthesia in a porcine model. Acta Anaesthesiol Scand 1994; 38: 473-478.
23. Messeter K, Nordström C-H, Sundbarg G, Algotsson L, Ryding E. Cerebral haemodynamics in patients with acute severe head trauma. J Neurosurg 1986; 64: 231-237.
24. Michenfelder JD. The interdependency of cerebral functional and metabolic effects following massive doses of thiopental in the dog. Anesthesiology 1974; 41: 231-236.
25. Michenfelder JD, Theye RA. Cerebral protection by thiopental during hypoxia. Anesthesiology 1973; 39: 510-517.
26. Nordström C-H, Messeter K, Sundbürg G, Schalen W, Werner M, Ryding E. Cerebral blood flow, vasoreactivity, and oxygen consumption during barbiturate therapy in severe traumatic brain lesions. J Neurosurg 1988; 68: 424-431.
27. Overgaard J, Tweed WA. Cerebral circulation after head injury. Part 2: The effects of traumatic brain edema. J Neurosurg 1976; 45: 292-300.
28. Upton RN, Ludbrook GL, Grant C, Gray EC. In vivo relationships between cerebral pharmacokinetics and pharmacodynamics of thiopentone in sheep after short-term administration. J Pharmacokin Biopharm 1996; 24: 1-18.
29. Pierce EC, Lambertsen CJ, Deutsch S, Chase PE, Linde HW, Dripps RD et al. Cerebral circulation and metabolism during thiopental anesthesia and hyperventilation in man. J Clin Invest 1962; 41: 1664-1671.
30. Shapiro HM, Galindo A, Wyte SR, Harris AB. Rapid intraoperative reduction of intracranial pressure with thiopentone. Br J Anaesth 1973; 45: 1057-1062.
31. Jennett B, Teasdale G, Galbraith S, Pickard J, Grant H, Braakman R et al. Severe head injuries in three countries. J Neurol Neurosurg Psychiatry 1977; 40: 291-298.
32. Miller JD. Significance and management of intracranial hypertension in head injury. In: Ishii S, Nagai H, Brock M (eds) Intracranial Pressure V. Springer, Berlin 1983; 44-53.
33. Miller JD Editorial. Barbiturates and raised intracranial pressure. Ann Neurol 1979; 6: 189-193.
34. Eisenberg HM, Frankowski RF, Contant CF, Marshall LF, Walker MD. High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg 1988; 69: 15-23.
35. Schwartz ML, Tator CH, Rowed DW, Reid SR, Meguro K, Andrews DF. The University of Toronto Head Injury Treatment Study: a prospective randomized comparison of pentobarbital and mannitol. Can J Neurol Sci 1984; 11: 434-440.
36. Ward JD, Becker DP, Miller JD, Choi SC, Marmarou A, Wood C et al. Failure of prophylactic barbiturate coma in the treatment of severe head injury. J Neurosurg 1985; 62: 383-388.
37. Abramson NS, Safar P, Detre KM, Kelsey SF, Monroe J, Reinmuth O et al. Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. Brain Resuscitation Clinical Trial I Study Group. N Engl J Med 1986; 314: 397-403.
38. Dean JM, McComb JG. Intracranial pressure monitoring in severe pediatric near-drowning. Neurosurgery 1981; 9: 627-630.
39. Kassell NF, Peerless SJ, Drake CG, Boarini DJ, Adams HP. Treatment of ischemic deficits from cerebral vasospasm with high dose barbiturate therapy. Neurosurgery 1980; 7: 593-597.
40. Samson DS, Beyer CM. Thiopental coma in the treatment of vasospam-induced cerebral ischemia/infarction. In: Wilkins RH (cd) Cerebral Arterial Spasm. Williams and Wilkins, Baltimore 1980; 634-636.
41. Moudgil GC. Effects of premedicants, intravenous anaesthetic agents and local anaesthetics on phagocytosis in vitro. Can Anaesth Soc J 1981; 28: 597-602.
42. Neuwelt EA, Kikuchi K, Hill SA, Lipsky P, Frenkel E. Barbiturate inhibition of lymphocyte function: differing effects of various barbiturates used to induce coma. J Neurosurg 1982; 56: 254-259.
43. Schalen W, Messeter K, Nordström C-H. Complications and side-effects during thiopentone therapy in patients with severe head injuries. Acta Anaesthesiol Scand 1991; 36: 369-377.
44. Schalen W, Sonesson B, Messeter K, Nordström G, Nordström C-H. Clinical outcome and cognitive impairment in patients with severe head injuries treated with barbiturate coma. Acta Neurochir 1992; 117: 153-159.
45. Turcant A, Delhumeau A, Premel-Cabic A, Granry J-C, Cottineau C, Six P et al. Thiopental pharmacokinetics under conditions of long-term infusion. Anesthesiology 1985; 63: 50-54.
46. Matta B, Menon D. Severe head injury in the United Kingdom and Ireland: a survey of practice and implications for management. Crit Care Med 1996; 24: 1743-1748.
47. Ghajar J, Hariri RJ, Narayan RK, Iacono LA, Firlik K, Patterson RH. Survey of critical care management of comatose, head-injured patients in the United States. Crit Care Med 1995; 23: 560-567.
48. Mirski MA, Muffelman B, Ulatowski JA, Hanley DF. Sedation for the critically ill neurologic patient. Crit Care Med 1995; 23: 2038-2053.
49. Stuart G, Yelland JDN, Balderson G. 3000 head injuries: a prospective study of patients admitted to Brisbane neurosurgical units. J Clin Neurosci 1998; 5: 402-405.
50. Eker C, Asgeirsson B, Grande P-O, Schalen W, Nordström C-H. Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation. Crit Care Med 1998; 26: 1881-1886.
51. Miller J, Dearden N, Piper I, Chan K. Control of ICP in patients with severe head injury. J Neurotrauma 1992; 9: s317-s326.
52. Miller JD, Becker DP, Ward JD, Sullivan HG, Adams WE, Rosner MJ. Significance of intracranial hypertension in severe head injury. J Neurosurg 1977; 47: 503-516.
53. Marshall LF, Smith RW, Shapiro HM. The outcome with aggressive treatment in severe head injuries. Part II: Acute and chronic barbiturate administration in the management of head injury. J Neurosurg 1979; 50: 26-30.
54. Rockoff MA, Marshall LF, Shapiro HM. High-dose barbiturate therapy in humans: a clinical review of 60 patients. Ann Neurol 1979; 6: 194-199.
55. Colohan A, Alves W, Gross C, Torner J, Mehta V. Tandon P et al. Head injury mortality in two centers with different emergency medical services and intensive care. J Neurosurg 1989; 71: 202-207.
56. Rosner MJ, Rosner SD, Johnson AH. Cerebral perfusion pressure: management protocol and clinical results. J Neurosurg 1995; 83: 949-962.
57. Overgaard J, Tweed WA. Cerebral circulation after head injury. Part 1: Cerebral blood flow and its regulation after closed head injury with emphasis on clinical correlations. J Neurosurg 1974; 41: 531-541.
58. Alberico A, Ward J, Choi S, Marmarou A, Young H. Outcome after severe head injury: relationship to mass lesions, diffuse injury and ICP course in pediatric and adult patients. J Neurosurg 1987; 67: 648-656.
59. A receptor. Br J Pharmacol 1999; 128: 77-82.
60. Cordato DJ, Herkes GK, Mather LE, Gross AS, Finfer SR, Morgan MK. Prolonged thiopentone infusion for neurosurgical emergencies: usefulness of therapeutic drug monitoring. Anaesth Intensive Care 2001; 29: 339-348.
61. Bleyaert AL, Nemoto EM, Safar P, Stezoski SW, Mickell JJ, Moossy J et al. Thiopental amelioration of brain damage after global ischemia in monkeys. Anesthesiology 1978; 49: 390-398.
62. Corkill G, Sivalingam S, Reiten JA, Gilroy BA, Helphrey MG. Dose dependency of the post-insult protective effect of pentobarbital in the canine experimental stroke model. Stroke 1978; 9: 10-12.
63. Hoff JT, Pitts EH, Spetzler R, Wilson CB. Barbiturates for protection from cerebral ischaemia in aneurysm surgery. Acta Neurol Scand 1977; 64(Suppl.): 158-159.
64. Hoff JT, Smith AE, Hankinson HE, Nielsen SE, Barbiturate protection from cerebral infarction in primates. Stroke 1975; 6: 28-33.
65. Nussmeier NA, Arlund C, Slogoff S. Neuropsychiatric complications after cardiopulmonary bypass: cerebral protection by a barbiturate. Anesthesiology 1986; 64: 165-170.
66. Agnoli A, Palesse N, Ruggieri S, Leonardis G, Benzi G. Barbiturate treatment of acute stroke. Adv Neurol 1979; 25: 269-274.
67. Spetzler RF, Selman WR, Roski RA, Bonstelle C. Cerebral revascularization during barbiturate coma in primates and humans. Surg Neurol 1982; 17: 111-115.
68. Morgan M, Halcrow S, Sorby W, Grinnell W. Outcome of aneurysmal subarachnoid haemorrhage following the introduction of papaverine angioplasty. J Clin Neurosci 1996; 3: 139-142.
69. Finfer SR, Ferch R, Morgan MK. Barbiturate coma for severe, refractory vasospasm following subarachnoid haemorrhage. Intensive Care Med 1999; 25: 406-409.
70. Dorsch N. Cerebral arterial spasm - a clinical review. Br J Neurosurg 1995; 9: 403-412.
71. Brodie MJ. Staus epilepticus in adults. Lancet 1990; 336: 551-552.
72. Chang CWJ, Bleck TP. Status epilepticus. Neurol Clin 1995; 13: 529-548.
73. Working Group on Status Epilepticus. Treatment of Convulsive Status Epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 1993; 270: 854-859.
74. Van Ness PC. Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin. Epilepsia 1990; 31: 61-67.
75. Yaffe K, Lowenstein DH. Prognostic factors of pentobarital therapy for refractory generalized status epilepticus. Neurology 1993; 43: 895-900.
76. Tasker RC, Boyd SG, Harden A, Matthew DJ. EEG monitoring of prolonged thiopentone administration for intractable seizures and status epilepticus in infants and young children. Neuropediatrics 1989; 20: 147-153.
77. Eriksson K, Baer M, Kilpinen P, Kolvikko M. Effects of long barbiturate anaesthesia on eight children with severe epilepsy. Neuropediatrics 1993; 24: 281-285.
78. Stecker MM, Kramer TH, Raps EC, O'Meeghan R, Dulaney E, Skaar DJ. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia 1998; 39: 18-26.
79. Feneck RO. A case of status epilepticus. Use of thiopentone and IPPV to control otherwise refractory convulsions. Anaesthesia 1981; 36: 691-695.
80. Burton K, Holland JT. Convulsive status epilepsy: is there a role for thiopentone-induced narcosis? Clin Exp Neurol 1984; 20: 47-56.
81. Rowan AJ, Scott DF. Major status epilepticus: a series of 42 patients. Acta Neurol Scand 1970; 46: 573-584.
82. Begemann M, Rowan AJ, Tuhrim S. Treatment of refractory complex-partial status epilepticus with propofol: case report. Epilepsia 2000; 41: 105-109.
83. Bhrer M, Maitre PO, Hung OR, Ebling WF, Shafer SL, Stanski DR. Thiopental pharmacodynamics. I. Defining the pseudo-steady-state serum concentration-EEG effect relationship. Anesthesiology 1992; 77: 226-236.
84. Hung OR, Varvel JR, Shafer SL, Stanski DR. Thiopental pharmacodynamics: II. Quantitation of clinical and electroencephalographic depth of anesthesia. Anesthesiology 1992; 77: 237-244.
85. Russo H, Urien S, Duboin M-P, Bres J, Bressotte F. Pharmacokinetics of high-dose thiopental sodium in patients with cerebral injuries. Influential factors on kinetic model and on parameter variability. Clin Drug Invest 1997; 13: 255-269.
86. Stanski DR, Mihm FG, Rosenthal MH, Kalman SM. Pharmacokinetics of high-dose thiopental used in cerebral resuscitation. Anesthesiology 1980; 53: 169-171.
87. Bonten M, Weinstein R. Bird's eye view of nosocomial infections in medical ICU: blue bugs, fungi and device-days. Crit Care Med 1999; 27: 853-854.
88. Richards M, Edwards J, Culver D, Gaynes R. Nosocomial infections in medical intensive care units in the United States. Crit Care Med 1999; 27: 887-892.
89. Huang JL, Mather LE, Duke CC. High-performance liquid chromatographic determination of thiopentone enantiomers in sheep plasma. J Chromatog B 1995; 673: 245-250.
90. Nguyen KT, Stephens DP, McLeish MJ, Crankshaw DP, Morgan DJ. Pharmacokinetics of thiopental and pentobarbital enantiomers after intravenous administration of racemic thiopental. Anesth Analg 1996; 83: 552-558.
91. Mark LC, Brand L, Perel JM, Carroll II FI. Barbiturate stemoisomers: direction for the future? Excerpta Medica Int Congr Ser 1977; 399(II): 143-146.
92. Christensen HD, Lee IS. Anesthetic potency and acute toxicity of optically active disubstituted barbituric acids. Toxicol Appl Pharmacol 1973; 26: 495-503.
93. Mather LE, Rutten AJ. Stereochemistry and its relevance in anaesthesiology. Curr Opin Anaesthesiol 1991; 4: 473-479.
94. Ariens EJ. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol 1984; 26: 663-668.
95. Andrews PR, Mark LC. Structural specificity of barbiturates, and related drugs. Anesthesiology 1982; 57: 314-320.
96. Egan TD. Stereochemistry and anesthetic pharmacology: joining hands with the medicinal chemists. Anesth Analg 1996; 83: 447-450.
97. Mather LE, Edwards SR, Duke CC. Electroencephalographic effects of thiopentone and its enantiomers in the rat: correlation with drug tissue distribution. Br J Pharmacol 1999; 128: 83-91.